DalsnaFinance › Analyst accuracy › BMO Capital Markets › AMGN target
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen
BMO Capital Markets cut their target price on shares of Amgen from $450.00 to $415.00 and set a "market perform" rating for the company in a research report on Monday, October 12th.
A fact about what BMO Capital Markets published, as reported by MarketBeat, not a recommendation from Dalsna Finance; BMO Capital Markets is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.